Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years (Q35667362)

9 August 2017

title

Immunogenicity and safety of ZOSTAVAX(®) approaching expiry potency in individuals aged ≥50 years (English)

1 reference

9 August 2017

Robert Arnou

1

1 reference

9 August 2017

Anne Fiquet

series ordinal

2

1 reference

9 August 2017

Stéphane Thomas

series ordinal

3

1 reference

9 August 2017

Christine Sadorge

series ordinal

4

1 reference

9 August 2017

language of work or name

1 reference

1 October 2011

1 reference

9 August 2017

1 reference

9 August 2017

volume

7

1 reference

9 August 2017

issue

10

1 reference

9 August 2017

page(s)

1060-1065

1 reference

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Herpes Zoster and Postherpetic Neuralgia: a review of the effects of vaccination

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Antiviral treatment for preventing postherpetic neuralgia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Vaccination against Herpes Zoster and Postherpetic Neuralgia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Immunosenescence: emerging challenges for an ageing population

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Clinical practice. Herpes zoster

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Herpes zoster in older adults

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Herpes zoster and quality of life: a self-limited disease with severe impact.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

The incidence of herpes zoster

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Reactivated and latent varicella-zoster virus in human dorsal root ganglia

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

A study of shingles and the development of postherpetic neuralgia in East London

12 July 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

A prognostic score for postherpetic neuralgia in ambulatory patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Challenges for vaccination in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Immunization to reduce the frequency and severity of herpes zoster and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Mortality in the first 2 years among infants born to human immunodeficiency virus-infected women in Harare, Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Decline in Varicella‐Zoster Virus (VZV)–Specific Cell‐Mediated Immunity with Increasing Age and Boosting with a High‐Dose VZV Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Aging, immunity, and the varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Declaration of Helsinki. Ethical principles for medical research involving human subjects.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256327

Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom

25 September 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.4161%2FHV.7.10.16480

Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years old

21 January 2018

1 reference

12 December 2020

Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial

1 reference

12 December 2020

Immune response of elderly individuals to a live attenuated varicella vaccine

1 reference

12 December 2020

Impact of herpes zoster and post-herpetic neuralgia on patients' quality of life: a patient-reported outcomes survey

1 reference

12 December 2020

Comparison of gpELISA and neutralizing antibody responses to Oka/Merck live varicella vaccine (Varivax) in children and adults

1 reference

12 December 2020

Postherpetic neuralgia

1 reference

12 December 2020

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.7.10.16480

1 reference

9 August 2017

1 reference

9 August 2017

1 reference